Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders (UPQUAL)

This study has been completed.
Sponsor:
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Information provided by (Responsible Party):
Kenzie Cameron, Northwestern University
ClinicalTrials.gov Identifier:
NCT00793455
First received: November 17, 2008
Last updated: October 24, 2011
Last verified: October 2011
Results First Received: September 1, 2011  
Study Type: Interventional
Study Design: Allocation: Randomized;   Endpoint Classification: Efficacy Study;   Intervention Model: Parallel Assignment;   Masking: Single Blind (Subject);   Primary Purpose: Health Services Research
Conditions: Colorectal Cancer Screening
Prevention & Control
Intervention: Behavioral: Educational outreach

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
This trial took place at a large urban academic primary care internal medicine practice in Chicago, IL. This trial was enrolling patients between October 2008 and May 2009.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
We used data contained in the clinic's electronic health record to identify eligible patients. All eligible patients were randomly assigned in equal numbers to either the control or intervention arms. All eligible patients were randomized and assigned to groups until we reached target study size.

Reporting Groups
  Description
Intervention Group Participants assigned to this group received a one-time educational intervention within one week of randomization. Educational intervention consisted of a letter from patient's physician, a brochure about colorectal cancer screening, and a DVD about colorectal cancer screening.
Usual Care Control Group Participants in this arm will receive normal care until outcome assessment is performed at 6 months following the placement of the order for the preventive service. They will be sent a letter reminding them to obtain the ordered preventive service test.

Participant Flow:   Overall Study
    Intervention Group   Usual Care Control Group
STARTED   314   314 
COMPLETED   314   314 
NOT COMPLETED   0   0 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Intervention Group Participants assigned to this group received a one-time educational intervention within one week of randomization. Educational intervention consisted of a letter from patient's physician, a brochure about colorectal cancer screening, and a DVD about colorectal cancer screening.
Usual Care Control Group Participants in this arm will receive normal care until outcome assessment is performed at 6 months following the placement of the order for the preventive service. They will be sent a letter reminding them to obtain the ordered preventive service test.
Total Total of all reporting groups

Baseline Measures
   Intervention Group   Usual Care Control Group   Total 
Overall Participants Analyzed 
[Units: Participants]
 314   314   628 
Age 
[Units: Years]
Mean (Standard Deviation)
 57.90  (7.1)   58.03  (6.6)   58.0  (6.9) 
Gender 
[Units: Participants]
     
Female   197   192   389 
Male   117   122   239 
Race/Ethnicity, Customized 
[Units: Participants]
     
White   144   132   276 
Black   79   77   156 
Hispanic   9   14   23 
Other/unknown   82   91   173 
Region of Enrollment 
[Units: Participants]
     
United States   314   314   628 
Number of visits in past 2 years 
[Units: Participants]
     
1-2   69   79   148 
 80   79   159 
 54   48   102 
>=5   111   108   219 
Colorectal Cancer (CRC) screening history 
[Units: Participants]
     
Ever screened   22   24   46 
Never screened   292   290   582 
Insurance Status 
[Units: Participants]
     
Private   245   236   481 
Medicare   56   63   119 
Medicaid   10   10   20 
Uninsured   3   5   8 


  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Colorectal Cancer Screening Completion.   [ Time Frame: 3 months post randomization ]

2.  Secondary:   Colorectal Cancer Screening Completion   [ Time Frame: 6 months post randomization ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
This study does not identify the timing of the intervention that would have the most impact. Mailings occurred 3 months or more after the order was placed, contacting patients sooner may have been more effective.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Kenzie A. Cameron, PhD, MPH
Organization: Northwestern University
phone: 312-503-3910
e-mail: k-cameron@northwestern.edu


Publications of Results:

Responsible Party: Kenzie Cameron, Northwestern University
ClinicalTrials.gov Identifier: NCT00793455     History of Changes
Other Study ID Numbers: 1R18HS017163-01 ( US NIH Grant/Contract Award Number )
Study First Received: November 17, 2008
Results First Received: September 1, 2011
Last Updated: October 24, 2011
Health Authority: United States: Institutional Review Board